TGFB1 and neoplasm: The immunosuppressed environment in transplant recipients particularly favors CSC expansion, as impaired immune surveillance fails to eliminate these tumor-initiating cells, while calcineurin inhibitors may inadvertently promote CSC survival through TGF-β pathway activation [218,219].